Aliases:This biomarker is also known as:
- soluble KIT variant 1,
- CD117 antigen,
- proto-oncogene c-Kit,
- v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,
- v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene-like protein,
- p145 c-kit,
- mast/stem cell growth factor receptor Kit,
- Piebald trait,
- Piebald trait protein,
- tyrosine-protein kinase Kit,
- proto-oncogene tyrosine-protein kinase Kit,
SCF-sR, also known as KIT, is the human homolog of the proto-oncogene c-kit. C-kit was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit. Human KIT is a tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KIT is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous lukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene.
|QA State:||Under Review|
There are no datasets associated with this biomarker.